A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

This study has been withdrawn prior to enrollment.

Sponsor:

Information provided by (Responsible Party):

Talon Therapeutics, Inc

ClinicalTrials.gov Identifier:

NCT00112060

First received: May 27, 2005

Last updated: May 30, 2012

Last verified: May 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Study Completion Date:	September 2011
Primary Completion Date:	September 2011 (Final data collection date for primary outcome measure)